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Abstract 
There are over 90 safe injection facilities (SIFs) in at least 11 countries around the world, except 
in the United States. SIFs are spaces where people who inject drugs (PWID) can bring their pre-
obtained drugs in a hygienic space and use them under supervision. The goal of these sites is to 
reduce the harmful effects of injection drug use and refer PWID to other medical, social, and 
treatment services. The Safer Inside Coalition, a community-driven health initiative, in the 
Tenderloin district of San Francisco recommended opening a SIF in the Tenderloin to improve 
the health of the community and individual drug users. The purpose of this project was to 
develop an operational plan for a SIF. Based on a literature review and coalition meetings, two 
operational plan models were developed – a centralized model and an integrated model. These 
were compiled in a report for community organizations to review to assess feasibility of 
implementing these services in the Tenderloin district. Further development needs to be done to 
work out more specific details based on the model that is chosen and the needs of the 
community. 
Keywords: harm reduction, injection drug use, Tenderloin, San Francisco, drug treatment, 
recovery  
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Executive Summary 
 There are approximately 7,000 people who inject drugs in the Tenderloin district of San 
Francisco. Many of these people are homeless and are injecting in public places and disposing 
their syringes in the street, endangering their lives and the community. The Safer Inside coalition 
is a community-driven health initiative that includes members of different organizations in the 
Tenderloin working towards improving the health and safety of the Tenderloin and drug users 
within the community. One of the priority recommendations for the group was to establish 
operational plans for a safe injection facility in the Tenderloin. 
 Safe injection facilities are legal spaces where people can bring pre-obtained drugs and 
use them under supervision in a hygienic environment. The goals of these facilities are to reduce 
morbidity and mortality, public drug use, discarded needles and HIV and Hepatitis C risks. They 
also serve as a linkage to drug treatment, health services, and social services. While there are no 
current safe injection services in the United States, this approach is being used in at least 10 other 
countries with over 90 sites worldwide. The two main models are centralized and de-centralized. 
A de-centralized model or integrated model is where safe injection services are added to an 
existing harm reduction program. A centralized or specialized site is one that is independent from 
other programs and whose purpose is just to provide supervised injection and education with 
referrals to other services.  
Based on the research from other models around the world and conversations with 
members of the Safer Inside coalition, two operational plans were developed – a specialized 
model and integrated model. These were presented in a report for executive directors of 
community organizations to view and discuss to determine which model would be the best fit for 
the community.  
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The report contains: 
• Background information about Safer Inside  
• Major assumptions that the plans were based on, including information from a 
law currently being debated in the California legislature on this topic  
• An overview of service for both models  
• A side-by-side outline of components for the two models 
• Justifications for the different program features, explaining what the 
recommendations were based on 
• Evaluation measures from an operational standpoint 
• Other considerations that need to be discussed 
• A preliminary budget for a specialized site was also added but the costs for some 
components still need to be added by organizations with more accurate numbers. 
The budget serves as a template for the coalition members and executive directors 
to start thinking about the different components that will be needed and can be 
adjusted based on the model that is chosen.  
This document is a preliminary document that can still be added to based on input from 
other stakeholders and other experts. These operational plans are designed to be used as a two-
year demonstration project and the impacts of the site are to be evaluated. There are advantages 
to each model and ultimately the goal is to clean up the streets of the Tenderloin and promote the 
health of people who inject drugs. 
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There are an estimated 22,500 people who inject drugs (PWID) in San Francisco (Chen, 
McFarland, & Raymond, 2016). The majority of them are homeless (68.6%) and almost half of 
them use heroin (San Francisco Department of Public Health [SFDPH], 2017). Furthermore, in 
San Francisco, PWID account for 21% of people with HIV and approximately 70% of active 
Hepatitis C infections (SFDPH, 2017). Death due to heroin, fentanyl, and methamphetamine in 
San Francisco has also been increasing in recent years. The city’s Tenderloin district has the 
largest percentage of unintentional opioid or stimulant deaths (33%) and the largest percentage of 
PWID (31%) (SFDPH, 2017). 
San Francisco has used a variety of harm reduction methods to treat the substance abuse 
disorders in the city such as providing syringe exchange programs and making it easier to obtain 
sterile syringes from pharmacies. The city also increased the availability of publicly-funded 
substance use treatment and medication-assisted treatment for opioid addiction. San Francisco 
was the first city in the United States to use public funds to increase the availability of naloxone 
to reduce the number of opioid overdoses (SFDPH, 2017).   
Despite these efforts, there is still a problem with public injecting, especially in the 
Tenderloin. Safe injection facilities (SIF) provide a safe space where PWID can inject drugs 
using clean supplies under supervision and which connects them to other social and health 
services. Safer Inside: A community-driven initiative for a healthier Tenderloin is a coalition 
comprised of members of different organizations in the Tenderloin working towards improving 
the health and safety of the Tenderloin and drug users within the community. One of the priority 
recommendations of the coalition was to develop operational plans for a SIF in the Tenderloin.  
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Review of Literature 
Harm Reduction Philosophy 
Harm reduction is a social policy that started gaining attention in the 1980s relating to 
drug use. It was introduced as an alternative to abstinence-only treatment for substance abuse. 
The priority in harm reduction is to decrease the harmful consequences of drug use, whereas, the 
priority of abstentionism is to reduce the prevalence of drug use (Pates & Riley, 2012). The main 
principles of harm reduction are: pragmatism, humanistic values, focus on harms, and hierarchy 
of goals. Pragmatism involves accepting that some use of drugs is normal or inevitable in 
society. Humanistic values focuses on respecting the dignity and rights of drug users without 
judgment on their use. Focus on harms is recognizing that the potential harm from use is more 
important than the extent of drug use. Finally, hierarchy of goals is where harm reduction 
programs focus on the most urgent needs (Pates & Riley, 2012).  
There are many different types of programs that fit into the category of harm reduction. 
These include needle/syringe exchange programs, opiate substitution therapies, and supervised 
injection facilities. There is strong evidence that opiate substitution therapies are effective in 
decreasing adverse effects of injecting drugs (Korsmeyer & Kranzler, 2009; MacArthur et al., 
2014). Another popular harm reduction method is syringe or needle exchange programs. These 
have been shown to reduce the incidence of HIV while also helping drug users connect with 
other services (Korsmeyer & Kranzler, 2009). Safe injection facilities are another form of harm 
reduction because they can be used to treat overdoses early and save lives.  
History of Safe Injection Services 
Safe injection facilities (SIF) or drug-consumption rooms (DCR) are defined as legally 
sanctioned facilities that allow for the hygienic consumption of pre-obtained drugs under 
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supervision (Kimber, Dolan, Van Beek, Hedrich, & Zurhold, 2003). The primary goals of these 
services are to reduce public drug use, morbidity and mortality, inappropriately discarded 
needles, HIV and Hepatitis C (HCV) risks, and to serve as a gateway to drug treatment, health 
services, and social services (Kimber et al., 2003). These spaces evolved from health and public 
issues related to large urban drug scenes that were not being addressed by existing programs. The 
establishment of a SIF was usually the result of a local effort to change policies to allow these 
services to be introduced (European Monitoring Centre for Drugs and Drug Addiction 
[EMCDDA, 2016) 
The first DCR was opened in Berne, Switzerland in 1986. Since then SIFs and DCRs 
have been established in Germany, Netherlands, Spain, Norway, Luxembourg, Denmark, Greece, 
France, and Switzerland with a total of 90 DCRs in Europe. Other European nations that are 
considering opening SIFs are Slovenia, Scotland, Ireland, and Belgium (European Monitoring 
Centre for Drugs and Drug Addiction [EMCDDA], 2017). There is one medically supervised 
injection site in Sydney, Australia and no official sites in Asia or South America (EMCDDA, 
2017).  
In 2003, Canada opened Insite in Vancouver, the first legally approved SIF in North 
America. It was allowed to operate as a research pilot program as an exception under the 
Canadian Controlled Drugs and Substances Act (Hedrich, 2004). In 2006, the Canadian federal 
government threatened to revoke the exemption which led to supporters taking the case to the 
Supreme Court. In September 2011, the Canadian Supreme Court made a unanimous ruling in 
favor of Insite staying open (Hyshka, Bubela, & Wild, 2013). Dr. Peter Centre in Vancouver is a 
clinic for people living with HIV/AIDs that also provides supervised injection services for 
members. It was approved for the same exemption as Insite (Lupnick, 2016). As of June 2017, 
SAFE INJECTION FACILITIES  8 
there were two more sites that opened in Surrey, B.C. These sites are the first that have been 
approved for allowing substances taken orally and nasally, in addition to injecting (Bains, 2017). 
Three sites in Montreal have also opened in June 2017, including the first mobile unit in North 
America (Laframboise, 2017). One more site has been approved for Montreal and three sites are 
set to be opened in Toronto (Lejtenyi & Gillies, 2017). There are no sites in the United States to 
this date but there are many cities in the country that are working towards opening a SIF (Project 
Inform, 2016).   
Supervised Consumption Models 
There are many different types of models for supervised consumption sites. The two 
basic models are integrated and specialized. The integrated model is where a consumption area is 
added to or integrated into an existing facility that provides services to drug users and the 
homeless population (Hedrich, 2004). The consumption area is a separate area where clients can 
safely use their drugs under supervision and is just one of many other services that are provided 
by the facility. There is typically a separate registration or check-in area for staff to control 
admission to the consumption area. The integrated model is the most common but there is 
substantial variation in how the centers operate and in the services they provide as these are 
dependent on the limitations of the facility where the SIF is co-located (Hedrich, 2004).  
Specialized facilities are stand-alone sites that are exclusively for people who use drugs. 
These are usually set up in places where open drug scenes are major factors in a city. Many of 
these facilities offer other services above supervision of drug consumption, such as needle 
exchange and drug-related medical care. They also serve as a connection to other services that 
their clients may need such as drug treatment programs, healthcare, and shelters for the homeless 
(Hedrich, 2004). 
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Other models for SIFs include mobile units and informal sites. Mobile units are usually 
large buses or vans that contain several injecting stations and have a staff member to supervise 
injection. These usually drive around the city to hit high drug volume areas. Informal sites are 
generally run by former and current drug users and are tolerated by law enforcement (Hedrich, 
2004).  
 Basic services that are offered in specialized and integrated models are needle exchange 
programs, basic medical care (i.e. to treat overdoses), education on safe using practices, and 
referral. Staffing varies considerably depending on the site; however, all have staff available for 
registration and supervision of consumption. In Europe, 60-70% of facilities offer access to a 
nurse or physician (EMCDDA, 2017).  
Impacts of Safe Injection Services 
In 2014, a systematic review was written on the evidence of the positive and negative 
consequences of safe injection services (Potier, Laprévote, Dubois-Arber, Cottencin, & Rolland, 
2014). There were seventy-five relevant articles included and the authors found that SIFs were 
effective in promoting safe injection practices, attracting marginalized injection drug users, 
reducing frequency of overdoses, and enhancing access to health care. There were no cases of 
overdose deaths within any of the facilities in which this was evaluated. In Vancouver, there was 
a 35% decrease in the number of lethal overdoses around the facility (Potier et al., 2014). 
Furthermore, SIFs were associated with reduced numbers of dropped syringes and public drug 
injections. They did not find any increase in drug use, drug trafficking, or crime in areas 
surrounding SIFs (Potier et al., 2014).  
While the studies indicated that there was not an increase in local people who use drugs 
around a SIF, there was not a decrease either (Potier et al., 2014). One of the limitations of the 
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studies included in this review is that most of the samples for these are convenience samples so it 
is difficult to determine how representative the results are for all people who use drugs. 
Furthermore, many of the places that are studied have eligibility requirements which means that 
there would be a subset of people who would not be able to utilize these services (Potier et al., 
2014).  
Barriers and Facilitators for Safe Injection Services in San Francisco 
United States. There are no legally sanctioned SIFs operating in the United States to this 
date. While there are no laws that allow or forbid SIFs, there is some controversy about how drug 
laws are interpreted creating some difficulty in establishing these services in the U.S. There are 
laws in 19 states that authorize syringe exchange programs and/or pharmacy syringe sales and 
these laws could be extended to include allowing injecting as well. However, there are issues 
involving the consumption and possession of illegal drugs on the premises (Beletsky, Davis, 
Anderson, & Burris, 2008).  
These issues are further complicated by how police want to enforce certain laws and the 
political climate. If police are not supportive and involved, there would be a risk that clients 
might be arrested for drug possession when they are entering a facility. There would also be risks 
for the staff members that work there, especially if they are licensed professionals. The situation 
can get complicated if a state or local government authorizes a SIF but the federal law 
enforcement agencies view it as a challenge to the existing national drug laws (Beletsky et al., 
2008). Furthermore, depending on the political party that has control of local, state, and federal 
government, enforcement and acceptability may change dramatically. 
There is also a lot of stigma associated with drug use and opponents of SIFs fear that it 
will increase drug use, condone drug use, or have a negative impact on public order (Semaan et 
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al., 2011). There are some people who have issues with interventions for injection drug users due 
to their negative attitudes towards this population. Access to funding may also be limited based 
on constrained budgets and how important an issue it is for the U.S. health care system (Semaan 
et al., 2011). 
San Francisco. There are many factors that might affect the success of a SIF in San 
Francisco. There has been some research into the feasibility and acceptability of establishing safe 
injection services in San Francisco. Recently, researchers estimated the economic costs and 
benefits of establishing a SIF in San Francisco, considering potential savings from averted HIV 
and HCV infections, reduced skin and soft tissue infection, averted overdose deaths, and 
increased medication-assisted treatment uptake. It was found that a $2.33 savings would be 
generated from each dollar spent on a SIF and would generate an annual net savings of $3.5 
million for a SIF with 13 booths (Irwin, Jozaghi, Bluthenthal, & Kral, 2016).  
Furthermore, there have been studies (Kral et al., 2010) done among injection drug users 
(IDUs) in San Francisco regarding their willingness to use a SIF. It was found that 85% of IDUs 
reported they would use a SIF, especially among those who have injected publicly (Kral et al., 
2010). However, in a qualitative study of community stakeholders in the Tenderloin where there 
is a lot of public injecting, many expressed concerns that a SIF might increase illicit activities 
and attract more IDUs to the neighborhood and increase the stigma associated with the 
Tenderloin (Wenger, Arreola, & Kral, 2011).  
In April 2017, the San Francisco Board of Supervisors passed a resolution for the 
Department of Public Health to form a Task Force to develop recommendations on safe injection 
services in San Francisco. They will submit a recommendation in three months from the first 
meeting to the Mayor and the Board of Supervisors (“Safe injection services task force,” 2017). 
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There is also a bill, AB 186, in the California Assembly to legalize injection drug use under the 
supervision of health care professionals (Eggman, Wiener, & Friedman, 2017). As of July 2017, 
this bill had already passed the California State Assembly and was in the California Senate. AB 
186 would allow specified counties or cities to authorize the operation of supervised injection 
services programs for adults that includes a hygienic space supervised by health care 
professionals where PWID can consume pre-obtained drugs, sterile consumption supplies, and 
access to referrals to substance use disorder treatment. This bill would exempt a person from 
existing criminal sanctions solely for actions or conduct on the site of a safer drug consumption 
services program authorized by the city or county (Eggman et al., 2017).  
Safer Inside: A Community-Driven Initiative for a Healthier Tenderloin 
Background 
 The Safer Inside coalition was founded in the spring of 2015. It started as a group of 
people working in the Tenderloin district who came together to discuss public safety. They were 
particularly concerned with the number of used needles on the street and how often public 
injecting was visible. The solution that the group came to was supervised injection services and 
so they became the “needle group”. This multi-sector community-driven collaboration is 
comprised of leaders representing business, education, philanthropy, public health, law 
enforcement, and social service non-profit organizations with the goal of improving the health of 
the Tenderloin community and individual drug user health.  
Coalition characteristics 
 The Safer Inside Coalition now consists of members from Dataway, DeMarillac 
Academy, Drug Policy Alliance, Episcopal Community Services, Glide, Gubbio Project, 
Hospitality House, St. Anthony Foundation, San Francisco AIDS Foundation, Urban Survivors 
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Union, Saint Francis Foundation, San Francisco DA’s Office, SF Department of Public Health, 
Mayor’s Office of Economic and Workforce Development, SF Tenderloin Police Department, 
and people who use injection drugs. Most of the group members are volunteers who participate 
in addition to their current jobs. The Tenderloin Health Improvement Partnership (TLHIP) with 
the support of Saint Francis Foundation hired an outside consultant to be the group organizer and 
provides incentives for people who use drugs to participate in the monthly meetings. 
Objectives and Action Steps 
The mission of the Safer Inside collaboration is to improve the health and safety for all 
persons who live, work or congregate in the Tenderloin, and to promote a humane response to 
persons who inject drugs (PWID) through a Four Pillars Approach to individual and community 
harm reduction. The Four Pillars framework is widely used in substance use harm reduction 
programs and focuses on prevention, harm reduction, treatment, and law enforcement. The Safer 
Inside group added “recovery” and “monitoring and evaluation” to the framework. Community 
members from each pillar were involved in the group. The objectives of the Safer Inside 
collaboration are to: 
1. Reduce the detrimental effects of substance use and addiction among persons who use 
injection drugs 
2. Reduce community exposure to improperly discarded needles and syringes 
3. Reduce public injecting drug behavior 
4. Increase the availability of syringe disposal options 
5. Increase opportunities for safer injection  
6. Help PWID to access services – medical, detox, and treatment 
Seven priority recommendations were identified which were:  
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• Provide peer outreach to people who inject drugs in the Tenderloin  
• Develop a public information campaign  
• Develop an operational plan to establish a supervised injection site  
• Develop an operational plan to establish a clinical detoxification facility,  
• Develop an operational plan to establish a drug user resource center  
• Enforce local practices for drug-related offenses 
• Support a research plan of a two to three-year demonstration project.  
Problem Analysis 
 It was decided, based on research from other harm reduction programs, that the best way 
to achieve the objectives of the Safer Inside coalition was to open a SIF in the Tenderloin district 
of San Francisco. Before organizations in the Tenderloin would feel comfortable with this, they 
needed to see operational plans on how it would work and how much it would cost. Furthermore, 
the coalition needed to decide whether an integrated or specialized model would be more 
appropriate or feasible in the Tenderloin.  
The goal of this capstone project was to develop two potential operational plans for 
specialized and integrated safe injection services for the Tenderloin district in San Francisco. 
These would be presented to executive directors of harm reduction programs in the Tenderloin to 
determine which model they would be able to support and what additional resources they may 
require to implement a SIF in the community. 
Methods 
Since official safe injection sites have never been operated in the United States, a 
thorough literature review was done to search for information on how safe injection sites have 
been operated in other countries. The review included peer-reviewed journal articles, websites, 
SAFE INJECTION FACILITIES  15 
and news articles. Information regarding operations was compiled to create a better 
understanding about the mechanics of operations with a focus on staffing, space allocation, 
restrictions, eligibility requirements, and services offered.  
Data were also collected from members of the Safer Inside coalition to assess what San 
Francisco-specific features they wanted to include. This information was gathered based on 
comments made during coalition meetings and during additional informal interviews and 
discussions with key members of the coalition. Most of the information gathered at this stage 
was general but notes were made from each conversation and were later analyzed to determine 
whether particular desired features emerged that differed from those in use in other sites. 
After collecting this information, an outline was made addressing different aspects of 
how two different models of safe injection sites might be run. The draft outline was presented to 
the coalition for their specific feedback. This was to obtain more detailed information from them, 
as well as give them a clearer vision of how safe injection facilities might look in San Francisco. 
The outline was distributed via google doc to members of the coalition and asking for their 
specific notes and recommendations about the different components. This approach resulted in 
feedback from only one member. Several weeks later, a conference call was set up between 
members of the coalition from harm reduction organizations that are potential hosts of a SIF. 
During this conference call, the points from the outline were discussed to agree on assumptions 
for the basis of safe injection services in the Tenderloin. This meeting was recorded and notes 
were taken to extract more questions and themes.  
Feedback from the stakeholders was synthesized with information from the literature 
review and then analyzed to put together a more detailed outline and a set of major assumptions 
for two different models (Figure 1).  
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Figure 1: Operational Plan Assumptions Outline Used in Coalition Meetings 
 
Major Assumptions for Centralized Location 
➢ Open 365 days/year 
➢ Start at 16 hrs/day 
➢ 15 booths (maximum) 
➢ Physical space 
▪ Reception/waiting room 
▪ Injecting area with area for resuscitation and sinks for washing hands 
▪ Chill out room 
▪ Bathrooms 
▪ Locked closet/storage for supplies 
▪ Private spaces for counseling/private medical services etc 
➢ Staffing 
▪ Licensed clinical personnel (2 present at all times) – according to Insite staffing 
▪ Peer health educators (7 present at all times) – according to Insite staffing 
▪ Medical/program director (only available 8 hrs/day) 
▪ Security officer (at all times) 
▪ Social worker (only available 8 hrs/day) 
➢ Services offered 
▪ Provide safe injecting supplies 
▪ Primary health care  
▪ Safer injecting education 
▪ Overdose prevention education 
▪ Counseling  
▪ Refreshments in chill out area 
▪ Clothes 
❖ Major Assumption for De-Centralized Location 
➢ Open during days/hours of site 
➢ 2 booths 
➢ Physical space 
▪ Use existing reception/check-in 
▪ Have injection booths in location where there is room for privacy but can be 
supervised by clinical personnel 
▪ Another space where client can hang out after injecting 
➢ Staffing 
▪ At least 1 licensed personnel 
▪ Peer health educators 
▪ Other staff support from existing organization 
➢ Additional service provided (on top of already existing services) 
▪ Provide safe injecting supplies 
▪ Primary health care (wound care, HIV and STI testing) 
▪ Safer injecting education 
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The outline was formed by utilizing the Supervised Injection Services Toolkit from 
Toronto for program components that needed to be considered (Toronto Drug Strategy 
Implementation Panel, 2013). Remaining, unanswered questions were noted (Appendix A). 
These drafts were presented at a monthly coalition meeting to elicit more feedback. Detailed 
notes were taken to extract more themes. Another meeting was scheduled with more key 
stakeholders, such as users and representatives from organizations to discuss and answer the 
remaining questions. Operations-related themes were taken from the Yes to SCS city-wide 
coalition meetings and the San Francisco Department of Public Health and Board of Supervisors 
Safe Injection Task Force meetings. 
The data for the budget was collected by contacting suppliers for needle exchange 
programs in San Francisco to estimate the costs of supplies. Data from government websites 
were used to collect information on average wages for staff. This information was collected and 
inputted into Excel based on the assumptions that were agreed upon in the operational plan. 
Findings 
 Based on the literature review and the discussions with the Safer Inside coalition 
members, the plan was based on a number of underlying assumptions: 
• Safe injection services are necessary for the health and safety of the community and drug 
users 
• The target population are PWID who are homeless and/or primarily use drugs in public 
areas in the Tenderloin 
• A SIF would be beneficial in the Tenderloin 
• A SIF would be able to get funding and support 
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• Success of the SIF would rely on utilizing good neighbor strategies by working with local 
law enforcement, businesses, and community members 
• The SIF would start as a 2-year demonstration project that would lead to more SIFs by 
year 3 
• Evaluations will be done to assess success by collecting data on who is using the service, 
how many referrals are being made, and health and neighborhood impacts (See Appendix 
B for more details) 
Overview for centralized model 
The centralized model is an example of a site that is an independent program (potentially 
supported by existing organizations) in the Tenderloin and would offer a safe, clean space for 
PWID to use under supervision. 
Service model for clients: 
1. Clients arrive at the reception area and check-in. On the first visit, demographic, risk 
behavior, injecting practices, and other healthcare and living situation measures (see 
Appendix B for types of questions) would be obtained for monitoring and evaluation 
purposes and the client would be given a unique identifier that they would use for entry at 
each future visit. Clients would also be asked about types of drugs being brought in at 
each visit and assessed for special needs/accommodations 
2. Clients would wait in reception until an injection booth is available and then they would 
proceed to the injecting area. 
3. At the injection area, clients would wash their hands and be given clean supplies and 
proceed to an injection booth where they would be given approximately 30 minutes to 
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inject (may take longer if necessary). Clients would be supervised by the staff and have 
the option of receiving education about safe injecting if needed. 
4. After successful injection, they would proceed to the user lounge where they can relax, be 
monitored by staff to ensure safety (e.g. prevent overdose) and talk to their peers and 
staff. Here, other referrals can be made if the client is interested. 
5. Clients can spend approximately an hour in the lounge and this can vary based on need 
and space requirements. 
Overview for de-centralized model 
The de-centralized (or integrated) model is an example of what would be added to an 
existing harm reduction program in the Tenderloin to provide a safe, clean space for PWID to use 
under supervision. 
In this setting, the service will look different depending on the program that it is 
integrated with; however, this is the basic model of how it will work for clients in this type of 
setting: 
1. Clients would check-in at a private area where demographic, risk behavior, injecting 
practices, and other healthcare and living situation measures (see Appendix B for types of 
questions) for monitoring and evaluation purposes would be collected and a unique 
identifier would be assigned. Clients would be asked about types of drugs being brought 
in each visit. 
2. While clients are waiting to use the injection booths, they could use the waiting rooms or 
space that already exists in the facility. 
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3. Clients would then go into the injecting area, wash their hands, and collect clean injecting 
supplies and inject their drugs at a booth under supervision. Other safe injecting 
education will be provided if needed. 
4. After successful injection, clients can spend time in the existing space of the facility for 
continued monitoring and clients can access the other services that the existing 
organization offers. 
Justifications for Program Features 
 The two operational plan outlines were divided into sections outlining the features that 
each model would include (see Appendix C for more details of what is included).  
Services offered. The proposed services are based on the literature of what other SIFs 
offer (EMCDDA, 2017; Hunt, 2006; Schaffer, Stover, & Weichert, 2014; Schatz & Nougier, 
2012) and based on conversations with the members of Safer Inside as to the key services they 
wanted to offer to the community. The services are also within the minimum requirements for 
safe consumption services outlined in AB 186 (Eggman et al., 2017). Within the integrated 
model, more services may be offered depending on what the facility already has to offer. 
Furthermore, if the SIF were to be integrated into a syringe-exchange program, the clean 
injecting equipment will already be available. 
Hours of operation. The hours suggested in the centralized site are a starting point; 
hours can be expanded or decreased as the budget allows. However, the starting point of two 8-
hour shifts allows for increased availability of the service, as evidence suggests that users would 
prefer a space to be open 24 hours a day, according to the San Francisco Board of Supervisors 
Task Force Meeting on July 21, 2017. Furthermore, the hours of 6am-2pm and 4pm-midnight 
were suggested by members of the coalition to provide services for those who need to use early 
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in the day and later in the evening. This also will help to bring public injecting indoors during 
morning and evening commute times. The hours for the de-centralized model can also be 
adjusted as needed based on the characteristics of the specific site. 
Physical design. The design for the centralized model is based on Insite in Vancouver 
and the medically supervised injection site in Sydney (the two models with the most research). 
The addition of curtains around a larger booth was suggested by members of the coalition to 
provide additional privacy for those who need to inject into more sensitive areas of the body and 
can be used for private medical care. The need for mirrors and sinks in the injecting areas are for 
better ability to monitor clients and promote clean practices. The user lounge is based on Insite as 
a comfortable area for clients to hang out after injection under supervision if needed. This would 
also be an area where they can talk to staff about referral to other services. 
For the de-centralized model, the recommendation is to have a private area for check-in is 
to keep this service separate from the other services that are offered at the facility and for 
evaluation purposes. It is also to protect the privacy of the clients who are there to use this 
service. The model for this could vary depending on the space restrictions of the existing 
program. The proposal of the use of the existing waiting room for monitoring of clients after 
using is to continue to make sure that clients are safe before sending them back out on to the 
streets. 
Staffing. The staffing was decided by coalition members based on presumed need. The 
reason that a licensed clinical staff is to be available at all times in both models is for 
demonstration purposes. It is the model that is used at many of the researched sites (EMCDDA, 
2017; Schaffer et al., 2014) and is required by AB 186 (Eggman et al., 2017). This is by no 
means the only model, and sites can be opened that do not have licensed clinical staff but this is 
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the proposition to increase safety and for compliance under AB 186. Peer health educators are 
used at Insite, and are supported by the coalition as they can assist in talking to clients and 
getting them comfortable and providing education and supervision. Peer health educators could 
also assist in cleaning up after each injection. In de-centralized sites, potentially two or more 
peer educators may need to be in place to have at least two people able to respond to a medical 
emergency and still have staff that can continue to monitor the other clients. If the existing 
program already has staff that can help monitor, it may not be necessary to add more staff. Safety 
monitors are essential for security of the site and help to de-escalate situations and AB 186 
mentions having adequate security in place.  
Supplies. Recommendation on supplies were based on input from syringe exchange 
programs and members of the coalition and on supplies that are listed at other sites. 
Service rules. Service rules were based originally on rules that are in place in other 
existing sites in other countries. However, due to some research on the consequences of having 
too many restrictions to access (Schaffer et al., 2014), the suggested rules were agreed upon by 
members of the coalition to make the site low-barrier. While there is a rule for clients to be over 
18 per AB 186, IDs will not be checked. The rules that were suggested reflect the goals of the 
coalition to serve the majority of PWID in the Tenderloin. 
Budget. The budget (see Appendix D) was set up with all the categories that need to be 
included for a specialized site based on the operational plan outline. It includes salaries for staff 
for a site that is open 16 hours per day with up to 15 booths. The numbers can be adjusted as 
needed depending on the model that is chosen and actual cost of services or items. There are still 
many gaps where the costs are unknown but can be determined by the organizations that are 
considering the development of a SIF. 
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Discussion and Implications 
 The operational plans were developed based on the literature review and feedback from 
community members. The two operational models presented gave an overview of how the 
program would work in each setting and what features would need to be included. The report 
presented to the group contains a basic introduction to the Safer Inside Coalition, the major 
assumptions the plan was based on, information about AB 186, an overview of service for both 
models, the outline of included features for both models, the justification of features, operational 
evaluation components, and other considerations that still have not been decided on. A 
preliminary budget was also added; however, it is not complete and there are pieces that still 
need to be determined. The plans are still an ongoing discussion as there are many factors that 
need to be considered and many different opinions on the model and features.  
Supporting and Opposing Forces 
 There are several factors that positively impact a specialized model. There is a lot of 
support within the harm reduction community for these services to be offered. It could be run by 
a memorandum of understanding with existing harm reduction programs so several programs 
could contribute to the site (either through funding, personnel, supplies, etc). A specialized model 
would also be easier to evaluate as it will focus just on the safe injection services and could serve 
a larger number of clients. However, some of the negative aspects of a specialized model are that 
it might not be able to provide many additional services and clients would then need to go to a 
different location for other services. It would also be more expensive due to rental costs of a 
building and starting a program from scratch. 
 The integrated model is the most popular model around the world (Hunt, 2006; Schaffer 
et al., 2014; EMCDDA, 2017). There are several harm reduction programs in the Tenderloin that 
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have already expressed interest in adding this service on to their program. It would allow PWID 
access to other services without having to go to a different location. It may be less expensive as 
many of the programs could use existing space, staff, and supplies. However, it may be difficult 
for other clients who are on opioid substitution therapy or going through detox to know that 
drugs are being used in the same facility and may lead to relapse. It would also put more 
responsibility and liability on the existing program and it would be harder to see an impact if 
there are a limited number of people who can be using the service. 
 The performance measures in Appendix B are an important part to ensuring that the SIF 
is successful and will continue to be supported. The evaluation plan is another piece of 
operations that needs to be expanded upon in further discussion. There will be data collected on 
every aspect of the program. For example, there would be a record of demographic, risk 
behavior, injecting practices, and other healthcare and living situation measures for clients; how 
often clients utilize the service; how many supplies are given out; what types of and how often 
safe injecting education is given; what types of and how often medical treatments are given; how 
many overdoses/reversals; and what types and how often are referrals to other services. 
Limitations of Methods 
There were several challenges that arose from the type of data collection utilized for this 
project. First, most of the data was collected from secondary sources because it could not be 
collected from primary sources due to the lack of SIS services in the United States. This made it 
difficult to find specific information on how SIS are run as the data were limited to whatever 
information was published. It also proved difficult to get responses from people in other 
countries that currently have these services.  
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Furthermore, it was difficult to plan for scenarios without specifics on where the SIS 
might be located (if it is a specialized model) or what organizations would house it (if it is an 
integrated model). For example, some organizations have connections with licensed healthcare 
professionals while others do not, so individual agency characteristics could limit the type of 
services that could be offered in a specific location. This information was important for an 
accurate outline for the operational plans. However, at the time of the study, this information was 
still not decided.  
Other challenges arose from working with a large group of people who were all very busy 
and had separate full-time jobs. It was difficult to get all these key people to weigh in and 
provide information that would be useful to the development of the project. This was further 
complicated by the fact that this coalition was also focusing on outreach to support this idea so 
there was a split in focus. Due to these challenges, the best way to get feedback from the 
members was to provide a hard copy of the drafts in a meeting that they had agreed to attend. 
Finally, if this project were repeated with more resources and time, it would be helpful to 
visit at least one of the already existing SIFs and get an existing operational plan that could serve 
as a model. It would also be helpful to conduct some primary data collection from stakeholders 
and users about components that are important to them in a SIF. However, this data has already 
been collected via a study conducted in 2010 and another recent survey in the fall of 2016 and 
beginning of 2017. Unfortunately, the results from the recent studies are restricted since the 
studies have not been published.  
Other Limitations 
 Due to time constraints and the difficulty in getting feedback from different key players, 
this operations outline is just the beginning. The proposal will undoubtedly be revised and added 
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to many times before a service model is agreed upon and implemented. There are many more 
stakeholders that should have a say in some of the program design and services that were not 
able to give their input due to the limited time in which this project was conducted. There are 
also the Yes to SCS coalition and the Department of Public Health’s task force working on this 
topic, so their input may have an impact on the final operational plan that gets approved.  
Furthermore, while the intent of the Safer Inside coalition is to open a SIF in the 
Tenderloin regardless of the bill that is in the California Legislature, if AB 186 does not pass it 
will raise more questions and concerns that would need to be addressed to protect the clients and 
staff of the facility. The federal government also does not have any exemptions to laws that 
would allow for SIFs and so there is always the added threat of the federal government 
interfering with operations.  
Recommendations for Next Steps 
 Moving forward, these plans should be built upon, adding more input from community 
members and PWID. There should also be people with legal expertise working with programs 
that are interested in being involved to address liability and licensing issues. Input and 
cooperation with the police is necessary to ensure that everyone agrees in terms of what is 
acceptable and what is not. The important part of a SIF, regardless of model, is for it to be a safe 
place for PWID, so policies need to be put in place to ensure safety. It would be helpful if people 
from other existing SIFs around the world could come to San Francisco and help to inform what 
works and what does not to make sure that the program that is designed will function well and 
reach the largest number of people. Continuing to educate the public and officials about the 
scientific benefits of SIFs is crucial to making it successful.  
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Appendix A: Questions Requiring Input from Coalition Members 
 
➢ How long will clients need to be in the facility? 
➢ What hours do we want for the centralized location? 
▪ 8 am – midnight 
▪ 6 am- 2pm, 4pm – midnight 
▪ Other? 
➢ What level of clinical personnel is needed? 
▪ Do we need them to provide prescriptions? (NP) 
▪ Assessments and treatment (Nurses) 
➢ Scope of practice for peer health educators 
▪ They can be trained in naloxone administration and CPR and assist with 
resuscitations or just focus on education  
➢ Scope of practice for social worker/counselors? 
➢ What other medical services are we offering besides emergency procedures, resuscitation, 
wound care, and HIV/STI testing) 
➢ What type of counseling are we going to offer? 
▪ Referral to services? 
▪ Therapy? 
➢ Service rules (other assumptions we need to agree on): 
▪ Restrictions on types of drugs allowed to inject 
• If so, which ones? What treatments do we need? 
▪ Restrictions on drug dealing on site 
▪ Restrictions on sharing drugs 
▪ Restrictions on body sites where people can inject 
▪ Assisted injection 
▪ Time limits for injecting or using chill out room 
▪ Verbal or physical violence 
▪ Limit of number of injections per visit 
▪ Expulsion for breaking rules (i.e. what would the length of expulsion be) 
▪ Dispute resolution process 
➢ Are we going to offer to test drugs?  
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Appendix B: Performance Measures 
• How much? 
o    # SIFs 
o    - Service utilization patterns 
o    # of people 
o    Frequency of use 
o    Number of new and existing clients of the broader health service 
o    Services accessed on site 
o    Reasons for using service 
o    # tests for HIV and other blood borne illnesses 
o    # overdose events treated successfully 
o    Service referral patterns (# and type of referrals) 
• How well? 
o    % who are referred to recovery services 
o    % who recover 
o    % of total TL IDUs who use services 
o    % repeat clients 
o    % satisfied with service 
o    % awareness of SIS in TL 
• Is anyone better off? 
o    Degree of successful referral 
o    % understand importance of referral 
o    % motivated to attend referral 
o    % attended one visit 
o    % attended repeat visits 
o    % reporting help-seeking behavior 
o    % exhibiting basic health and hygiene 
o    % of peers responding effectively to overdose offsite 
• Health impacts: 
o    o Incidence of HIV, ep C, hep B infections 
o    o Incidence of abscesses and other skin/vein related problems 
o    #% fewer overdose deaths or overdoses 
o    #/% of successful recoveries 
 
*Important to note that impacts will be seen/measured in a several block radius of the site as that 
is the expected area to have the greatest impact 
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Appendix C: Program Details Outline for Both Models 
 
Outline for Centralized Model Outline for De-centralized Model 
Services offered: Services offered (in addition to services 
already provided): 
• Provide safe injecting supplies – such 
as syringes, alcohol, cookers, sterile 
water, tourniquets, etc. and safe 
smoking supplies 
• Provide safe injecting supplies – such 
as syringes, alcohol, cookers, sterile 
water, tourniquets, etc. 
 
• Referral to primary health care – 
connecting clients to health care 
providers so that they are in the health 
care system and are not relying on 
expensive emergency department 
visits 
• Treat immediate health concerns 
directly related to injecting – this 
includes treating overdoses, wound 
care for injection related wounds, 
administration of oxygen and other 
medications related to adverse 
reactions of drug use, and calling 
paramedics if further emergency 
medical attention is required 
 
• Treat immediate health concerns 
directly related to injecting – this 
includes treating overdoses, wound 
care for injection related wounds, 
administration of oxygen and other 
medications related to adverse 
reactions of drug use, and calling 
paramedics if further emergency 
medical attention is required 
• Harm reduction education 
o Safer injecting education, such 
as vein care, sterile practices, 
nutrition, dosing, appropriate 
disposal of equipment, HIV 
and HCV prevention 
education, etc. 
o Overdose prevention education 
o Support for long-term users  
• Harm reduction education 
o Safer injecting education, such 
as vein care, sterile practices, 
nutrition, dosing, appropriate 
disposal of equipment, HIV 
and HCV prevention 
education, etc. 
o Overdose prevention education 
o Support for long-term users 
• Harm reduction counseling  
o This would include linkages to 
treatment, detox, other 
counseling services, opioid 
replacement therapies 
 
• Testing for fentanyl on request with 
fentanyl testing strips 
• Testing for fentanyl on request with 
fentanyl testing strips 
Hours of operation: Hours of operation: 
• Open 365 days/year 
• Start at 16 hours/day (two 8-hour 
shifts) 
• Open during days/hours of the 
existing program 
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• Proposed hours: 6am-2pm, 4pm - 
midnight 
• May expand hours or offer this service 
at different hours depending on the 
site 
Physical design: Physical design: 
Reception/waiting room 
• space where clients can check-in and 
wait for booth to become available. 
This room would contain seating and 
water filtration system and cups so 
clients have access to water while they 
wait.  
 
Private area for check-in 
• There could be different models 
depending on the agency to promote 
privacy (For example, could be a 
small desk off to the side, an 
administrator collecting information 
with a laptop or tablet)   
 
Injecting area 
• contain up to 15 booths or injecting 
stations, each booth would consist of a 
table (that is easily sanitized), chair, 
and mirrors. There would be a nurses’ 
station for supplies, at least one sink 
for washing hands, and a disposal area 
for used equipment. Mirrors placed on 
either end of the room to make it 
easier for monitoring clients. There 
could be a booth at the end or corner 
of the room with curtains that come 
around for more privacy (if needed). 
Injecting area 
• contains minimum of 2 booths or 
injecting stations, each booth would 
consist of a table (that is easily 
sanitized), chair, and mirrors. There 
would be at least one sink for washing 
hands and a disposal area for used 
equipment. There would also be a 
supervision area or table containing 
supplies and emergency equipment 
and crash cart. Must be enough space 
for supervision of injections 
 
User lounge 
• safe space with seating for clients to 
utilize after injecting to continue to be 
monitored and talk with staff and 
peers 
Clients could use existing waiting 
room for waiting before and after injection 
Bathrooms  
Private space that can be used to store 





Licensed clinical personnel (minimum 
RN, 1 per shift) 
• their role would be for treatment such 
as medical emergency, wound care, 
and referral to other medical services 
Licensed clinical personnel (minimum 
RN) 
• one nurse for supervision and for 
treatment such as medical 
emergencies and wound care. 
 
Peer health educators (minimum 4 per 
shift) 
Peer health educators (minimum 1 per 
shift) 
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• there would be one in reception, at 
least 2 in injecting area for 
observation and can assist with 
administering naloxone and other 
safer injecting education, and one in 
user lounge for supervision and 
referral to services  
• for monitoring clients after injection 
and can also provide some harm 
reduction education  
 
Administrator (1 per shift) 
• work in reception and check-in all 
clients and collect data 
Administrator (1 per shift) 
• work in reception and check-in all 
clients and collect data 
 
Program manager (can work 40 
hrs/wk, but be available on-call) 
• this would be the manager of the 
facility  
Depending on existing program staff, 
may need additional staff because two people 
must be available at all times to respond to 
medical emergencies 
 
Medical director (sub-contracted) 
• available for managing more complex 
medical issues 
 
Safety monitor (at least 1 per shift) 
• helps provide a safe environment for 
staff, clients, volunteers, and other 
occupants of the SIF by means of 
crisis intervention and conflict de-
escalation 
 
Navigator (1 per shift) 
• Navigators work with clients who are 
not in care to identify factors 
contributing to a lack of engagement, 
such as a loss of health benefits, 
substance use, mental illness and 
homelessness.  Navigators work to 
address these barriers by providing 
referrals to social services, and assist 
with re-linking clients to care 
 
 
Program associate (40 hrs/wk) 








• Experience working with PWID 
Key qualifications 
• Non-judgmental 
• Experience working with PWID 
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• Understanding of harm reduction 
principles 
• Understanding of overdoses, 
HIV/HCV infections, substance use 
treatment modalities, homelessness, 
stigma, etc 
• Understanding of harm reduction 
principles 
• Understanding of overdoses, 
HIV/HCV infections, substance use 




• Universal precautions – 
prevent/respond to needle-stick 
injuries 
• Wound care/assessment 
• Stimulant overdose training 
• Naloxone training – DOPE  
• Safe handling of biohazards such as 
injecting supplies 
• De-escalation training 
• Crisis training 
• Cross-culture training 
Training: 
• CPR 
• Universal precautions – 
prevent/respond to needle-stick 
injuries 
• Wound care assessment 
• Stimulant overdose training 
• Naloxone training - DOPE 
• Safe handling of biohazards such as 
injecting supplies 
• De-escalation training 
• Crisis training 
• Cross-culture training 
Supplies: Supplies: 
Wound care supplies – gauze, 
bandages, saline, tape, lidocaine, long q-tips, 
antibiotic ointment, towels 
Wound care supplies – gauze, 
bandages, saline, tape, lidocaine, long q-tips, 
antibiotic ointment, towels 
Naloxone Naloxone 
Oxygen tanks, masks, tubing Oxygen tanks, masks, tubing 
Sharps container Sharps container 
Safe injecting supplies – syringes, 
tourniquets, alcohol swabs, sterile 
water/saline, cookers, pill filters, lighters 
Safe injecting supplies – syringes, 
tourniquets, alcohol swabs, sterile 
water/saline, cookers, pill filters, lighters 
Clean smoking supplies – rubber stem 
tips, alcohol swabs, copper chore boy, sugar-
free gum 
 
Universal precautions – gloves, 
masks, eye wear, soap for handwashing, hand 
sanitizer, paper towels 
Universal precautions – gloves, 
masks, eye wear, soap for handwashing, hand 
sanitizer, paper towels 
Cleaning agents Cleaning agents 
Fentanyl testing strips Fentanyl testing strips 
Service Rules: Service Rules: 
At least 18 years of age At least 18 years of age 
Only injectable drugs  Only injectable drugs 
All drugs must be procured prior to 
entering the site 
All drugs must be procured prior to 
entering the site 
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No sharing of drugs brought into site No sharing of drugs brought into site 
Staff will not assist injection Staff will not assist injection 
Estimate 30 min per injection, 
estimated hour in lounge based on need and 
space requirements 
Estimate 30 min per injection, 
estimated hour in lounge based on need and 
space requirements 
Protocols will be in place for the 
safety and well-being of all people (such as 
those from existing behavioral protocols from 
harm reduction agencies) 
Protocols will be in place for the 
safety and well-being of all people (such as 
those from existing behavioral protocols from 
harm reduction agencies) 
No limit on times clients can use the 
site, however, they need to get back in line 
after use  
No limit on times clients can use the 
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Appendix D: Preliminary Budget 
 
Budget for Centralized Site 
     
       
Assumptions: 
     
30 min per injection: 2 injections per hour per booth 
    
60 min in user lounge 
    
Check in: 
      
15 min for first time 
    
5 min for return visit 
     
       
       
This budget is based on centralized site, open 16 hours/day, up to 15 booths - potentially 480 
injections per day 
Salaries FT
E  











Peer Health Eds 8 $17.50 $36,400 $12,740 $49,140 $393,12
0 
Administrator 2 $20 $41,600 $14,560 $56,160 $112,32
0 
Program Manager 1 $35 $72,800 $25,480 $98,280 $98,280 
Safety Monitor 4 $18 $37,440 $13,104 $50,544 $202,17
6 
Navigator 2 $24 $49,920 $17,472 $67,392 $134,78
4 
Program Associate 1 $22 $45,760 $16,016 $61,776 $61,776 
Relief Staff 2 $22 $45,760 $16,016 $61,776 $123,55
2      
Total: $1,462,9
68        
Staff Development 
 
Total cost for all staff - to be done at start of program, 
may need to be repeated on annual, bi-annual basis 
depending on staff turn-around 
CPR plus First Aid 
 
$2,200 




















    
Harm Reduction training 0 
    
       
Program Expenses/Start up  
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Equipment and Supplies Qu
ant
ity 
Total Cost for quantity listed 
  
Sterile tables 15 $2,000 
    
Mirrors 15 $400 
    
Chairs  60 $3,000 
    
Reception desk 1 $1,500 
    
Staff counter with storage 1 $3,000 
    
Observation mirrors 2 $200 
    
Dividers 15 
     
Curtains 2 
     
SInk 1 
     
Water dispenser 3 $300 
    
Lighting 
      
Metro shelving 
      
Crash cart for nursing station 1 $500  for empty cart, not including 
supplies 
 
Staff desks 3 
     
Folding tables 3 $250 
    
Walkie talkie/radios 4 $800 
    
Lockers for staff 12 $1,000 
    
       
Office Supplies 
      
Computers (1 for each room, for data 
collection, and 1 for program 
manager and 1 for program 
associate) 
5 $5,000 
    
Phones 5 
     
Internet connection 12 $400 
    
Printer 2 
     
       
Office Expenses 
      
Paper 
      
Pens 
      
Printer cartridges 
      
Clipboards 
      
General 
      
Paper cups 
      
       
Custodial Supplies 
      
Mops 
      
Brooms 
      
Cleaning agents 
      
Biohazard kits 
      
Blood-cleanup kits 
      
Sanitizing wipes 
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Soap 
      
Paper towels 
      
       
Operating supplies 
      
Medical: 
      
Wound care supplies 
      
Naloxone $0 via DOPE 
project 
    
Oxygen/oxygen tubing/masks 
     
Universal precautions 
      
Fentanyl testing strips 
      
       
Injectng supplies: 
      
Syringes $132/case of 
500 
    
Cotton $17/case of 
600 
    
Tourniquets $130/case of 
800 
    
Alcohol swabs $33/case of 
4,000 
    
Sterile water/saline $125/case of 
1,000 
    
Cookers 
      
Pill filters $230/case of 
1,000 
    
Lighters $16/case of 
100 
    
Sharps containers $176/case of 
100 
    
       
Program Expenses 
      




     
Recruitment 
      
Utilities 
      
Internet/Phone 
      
Rent 
      
Insurance 
      
Graphic design 
      
Branding 
      
T-shirts/scrubs 
      
Promotional materials 
      
Information and referral materials 
     
       
Professional Services (All these are sub-contracted, not regular staff): 
  
MD - not full-time staff, just available for complex medical issues and/or 
prescriptions 
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Maintenance 
      
Biohazard pickup 
      
Custodial 
      
Legal 
      
Security  




     
 
